Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 257 | 412 | 272 | 295 | 204 |
| Cost of Goods | 153 | 214 | 109 | 124 | 71 |
| Gross Profit | 104 | 198 | 163 | 171 | 133 |
| Operating Expenses | 2,135 | 2,172 | 2,668 | 2,465 | 3,202 |
| Operating Income | -1,878 | -1,760 | -2,396 | -2,170 | -2,998 |
| Other Income | 49 | 43 | 18 | -715 | -2,591 |
| Pre-tax Income | -1,829 | -1,717 | -2,378 | -2,885 | -5,589 |
| Net Income Continuous | -1,829 | -1,717 | -2,378 | -2,885 | -5,589 |
| Net Income | $-1,829 | $-1,717 | $-2,378 | $-2,885 | $-5,589 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.03 | -0.04 | -0.09 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.03 | -0.05 | -0.09 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.03 | -0.04 | -0.09 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.03 | -0.05 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.02 | -0.03 | N/A | N/A |
| EBITDA(a) | $-1,721 | $-1,615 | $-2,234 | $-2,006 | $-2,838 |